Showing results (81-90 of 676) with videos related to
Sort By:
Pageof 68
Clinical Advances in Hematology & Oncology : H&O|September 27, 2017
The next frontier in non-small cell lung cancer: synergizing radiation therapy and immune checkpoint blockadeKhinh Ranh Voong, Jarushka Naidoo, David S EttingerClinical Advances in Hematology & Oncology : H&O|September 27, 2017
New treatments for stage I testicular cancerLucia Nappi, Craig R Nichols, Christian K KollmannsbergerClinical Advances in Hematology & Oncology : H&O|September 27, 2017
Emerging treatments in acute myeloid leukemia: current standards and unmet challengesMary-Elizabeth Percival, Elihu EsteyClinical Advances in Hematology & Oncology : H&O|July 28, 2017
Combined blockade of vascular endothelial growth factor and programmed death 1 pathways in advanced kidney cancerDavid J Einstein, David F McDermottClinical Advances in Hematology & Oncology : H&O|July 6, 2016
Long-term outcomes of neoadjuvant treatment of HER2-positive breast cancerBingnan Zhang, Sara HurvitzClinical Advances in Hematology & Oncology : H&O|January 10, 2018
Monitoring multiple myelomaKyle A Udd, Tanya M Spektor, James R BerensonClinical Advances in Hematology & Oncology : H&O|August 8, 2007
Intensity-modulated radiotherapy for head and neck cancerHale B Caglar, Aaron M AllenClinical Advances in Hematology & Oncology : H&O|August 8, 2007
Use of hypomethylating agents in myelodysplastic syndromesEhab Atallah, Guillermo Garcia-ManeroClinical Advances in Hematology & Oncology : H&O|July 26, 2008
Serum CA125 and PSA concentrations in patients with lymphomaPeter H WiernikClinical Advances in Hematology & Oncology : H&O|November 11, 2008
Utility of bortezomib retreatment in relapsed or refractory multiple myeloma patients: a multicenter case seriesJeffrey Wolf, Paul G Richardson, Michael Schuster, et al.Pageof 68